Phytochemical compositions of extract from peel of hawthorn fruit, and its antioxidant capacity, cell growth inhibition, and acetylcholinesterase inhibitory activity by Panpan Wu et al.
RESEARCH ARTICLE Open Access
Phytochemical compositions of extract
from peel of hawthorn fruit, and its
antioxidant capacity, cell growth inhibition,
and acetylcholinesterase inhibitory activity
Panpan Wu1,2, Fajie Li3,4, Jianyong Zhang5, Bin Yang2*, Zhaojie Ji1 and Weidong Chen1
Abstract
Background: Hawthorn fruit (HF) is a well-known traditional medicine in China with the effects of improving
digestion and regulating qi-flowing for removing blood stasis. Modern pharmacological experiments showed that
HF extract has various pharmaceutical properties and flavonoids are considered as the main bioactive compounds.
In this paper, Diaion HP-20 adsorption chromatography was used to enrich flavonoids in PHF, and the
phytochemical composition of EPHF was analyzed by high performance liquid chromatography (HPLC) and liquid
chromatography tandem mass spectrometry (LC-MS). In addition, EPHF’s antioxidant capacity, acetylcholinesterase
(AChE) inhibitory activity and cytotoxic activity were evaluated.
Methods: EPHF was obtained by Diaion HP-20 adsorption chromatography. Phytochemical composition of EPHF
was analyzed qualitatively and quantitatively using HPLC and LC-MS. Radical scavenging capacity of EPHF was
estimated using 2,2-diphenyl-1-picryhydrazyl (DPPH) assay and oxygen radical absorbance capacity (ORAC) assay.
The AChE inhibitory activity of EPHF was evaluated by Ellman method. Cytotoxic activity of EPHF was assessed by
means of MTT assay.
Results: Eight kinds of components were identified, in which ideain with the value of 179.4 mg/g was identified to
be present in the highest level in EPHF, followed by (−)-epicatechin, chlorogenic acid, cyanidin 3-arabinoside,
hyperoside and isoquercitrin at the concentrations of 40.9, 10.0, 1.4, 0.4 and 0.2 mg/g, respectively. The contents of
these compounds in EPHF were much higher than those in PHF and HF. In addition, EPHF exhibited strong
antioxidant and AChE inhibitory activity (ORAC value: 11.65 ± 2.37 μM Trolox equivalents (TE)/mg, DPPH IC50 value:
6.72 μg/mL, anti-AChE activity IC50 value: 11.72 μg/mL) compared with PHF and HF. Moreover, EPHF exhibited high
levels of cytotoxicity on MCF-7 and SKOV-3 human tumour cell lines in a dose-dependent manner with the IC50 of
2.76 and 80.11 μg/mL, respectively.
Conclusions: Macroporous resin is useful for the extraction and separation of the total flavonoids from PHF. The
contents of flavonoids especially anthocyanin in EPHF were increased significantly compared with the PHF, and
EPHF exhibited strong antioxidant, AChE inhibitory activity and cytotoxicity on human tumour cells.
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Background
Medicinal plants are one of the most important sources
of medicinal agents and their beneficial healing effects
have been well demonstrated in ancient human civiliza-
tions worldwide. Hawthorn is distributed in the
Northern Hemisphere mostly in China, Europe and
North America [1] and has a long history of usage as a
traditional medicine. In Europe and America, the extract
of hawthorn leaves and flowers (eg. WS 1442, LI 132)
are used for the treatment of hypertension and heart dis-
ease [2–4]. In China, hawthorn fruit (HF) has the effects
of improving digestion and regulating qi-flowing for re-
moving blood stasis. HF not only commonly be used as
a traditional digestant, but also be combined with other
Chinese medicines to treat cardiovascular diseases, for
example, HF and Danshen (the root of Salvia miltior-
rhiza Bge.) are used together to treat coronary disease
and hyperlipemia. Modern pharmacological experiments
showed that HF extract has anti-tumour, antioxidant [5],
anti-aging and prevention of Alzheimer’s effects [6–8].
HF extract also has the beneficial effects on the cardio-
vascular system [9–12].
Flavonoids are considered as the main bioactive com-
pounds of HF, however, the content of flavonoid in HF is
rather low (only about 10 mg/g) [13, 14], while the con-
tent of sugar is high, which impedes the clinic usage of
HF further. If we can get a flavonoid-rich extract from
HF, we will make effective utilization of HF. So, the pur-
pose of our research is to get a flavonoid-rich extract
from HF, to estimate its pharmacological activities, to
find its potential possibility on clinical application. Our
previous work showed that the flavonoids found in HF
could also be found in the peel of hawthorn fruit (PHF)
with higher concentration. In addition, macroporous
resin has successfully been applied in the preparative
separation of total flavonoids in natural products [15]. In
the present study, extract with high content of flavo-
noids, especially anthocyanin, from the PHF (EPHF) was
obtained by Diaion HP-20 adsorption chromatography
with 20% aqueous ethanol elution. Phytochemical com-
position of EPHF was analyzed qualitatively and quanti-
tatively using high performance liquid chromatography
(HPLC) and liquid chromatography tandem mass spec-
trometry (LC-MS). At the same time, the antioxidant
capacity, acetylcholinesterase (AChE) inhibitory activity
and cytotoxic activity of EPHF were evaluated. To the
best of our knowledge, this is the first time to get the ex-
tract with rich content of anthocyanin from HF and
evaluate its pharmacological activity.
Methods
Materials and reagents
Fresh fruit of Crataegus pinnatifida Bge. var. major N.
E. Br. was collected from Beijing China, and identified
by Prof. Bin Yang. A voucher specimen (NO. 20160118)
was deposited at Institute of Chinese Materia Medica,
China Academy of Chinese Medical Sciences. The MCF-
7, SKOV-3 cell lines were obtained from the State Key
Laboratory of Biotherapy in Sichuan University (Sichuan,
China). Cyanidin 3-arabinoside and ideain were pur-
chased from Sigma (St. Louis, MO, USA). Chlorogenic
acid, (−)-epicatechin, hyperoside and isoquercitrin were
purchased from National Institute for Food and Drug
Control (Beijing, China). Procyanidin B2 was purchased
from Phytolab (Vestenbergsgreuth, Germany). Diaion HP-
20 was purchased from Mitsubishi Chemical Co. Ltd.
(Tokyo, Japan). Fluorescein disodium salt (FL), 2,2′-Azo-
bis(2-methylpropionamidine) dihydrochloride (AAPH), 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium
bromide (MTT), 2,2-Diphenyl- 1-picrylhydrazyl (DPPH),
AChE, acetyhhiocholine (ATCI), 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox), 5,5′-
dithiobis- (2-nitrobenzoic acid) (DTNB) were purchased
from Sigma (St. Louis, MO, USA). Dulbecco’s modified
Eagle’s medium (DMEM), trypsin, penicillin and strepto-
mycin were purchased from HyClone Laboratories Inc.,
(South Logan, UT, USA). Tris was purchased from
Amresco (Solon, OH, USA). HPLC grade acetonitrile and
methanol were purchased from Fisher (Fisher Scientific
USA). All the other chemicals used from commercial
sources were of analytical or higher grade.
Sample preparation
Preparation of EPHF
The peel and flesh of HF were separated and then the
peel was lyophilized by lyophilizer (Christ, Germany).
The dried PHF was milled into fine powder in a high-
speed disintegrator and passed through a 40-mesh sieve
before extraction. A sample of 1.0 g of powder was ex-
tracted three times with 10 mL of 95% ethanol contain-
ing 0.1% (v/v) trifluoroacetic acid at room temperature
for each extraction. The whole process of extraction
needs to be protected from light. The extract solutions
obtained from three extractions were combined, and fil-
tered. Subsequently, the extract solution was concen-
trated with a vacuum rotary evaporator (Buchi, Swit
Zerland) at 40 °C, and then chromatographed on a Dia-
ion HP-20 macroporous resin column, eluted subse-
quently with water, 20%, and 60% ethanol all containing
0.1% (v/v) trifluoroacetic acid. The fraction eluted by
20% ethanol containing 0.1% (v/v) trifluoroacetic acid
was collected, concentrated with a vacuum rotary evap-
orator and lyophilized.
Preparation of the tested sample
The accurately weighed EPHF was dissolved in methanol
and filtered by 0.22 μm membrane.
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The accurately weighed PHF powder (ca. 1.0 g) was
sonicated with 20 mL of 60% ethanol (pH 2) for 10 min
at 30 °C, and then centrifuged 10 min at 10,000 rpm,
and filtered by 0.22 μm membrane.
Preparation of the standard solution
The standards of cyanidin 3-arabinoside, ideain, chloro-
genic acid, (−)-epicatechin, hyperoside , isoquercitrin and
procyanidin B2 were accurately weighed (ca. 10 mg) , sub-
sequently, dissolved and diluted with methanol.
Identification of compounds by LC-MS
The analysis was performed on an ultimate 3000 ultra-
performance liquid chromatography system coupled to
an LTQ Orbitrap mass spectrometer via electrospray
ionization (ESI) interface from Thermo Fisher Scientific
(Bremen, Germany). This chromatography system con-
sisted of an autosampler, a PDA detector, a column com-
partment and a quaternary pump. The mass spectra
were recorded in simultaneous positive ionization full-
scan mode throughout the m/z range 50 ~ 800, ion spray
voltage 3.5 kV, capillary temperature 350 °C , sheath gas
flow rate 50 psi, aux gas flow rate 10 psi.
Determination of compounds by HPLC
The analysis was performed on an HPLC system
(Shimadzu LC-20AT, Tokyo, Japan) consisting of a pump
(LC-20A, Tokyo, Japan), a photodiode array detector
(SPD-M20A photodiode array detector, Tokyo, Japan),
and an Agilent Zorbax Extend C18 column (4.6 ×
250 mm, 5 μm) with a solvent flow rate of 0.8 mL/min
at 35 °C. Water and acetonitrile both with 2% formic
acid were used as the mobile phase A and B, respect-
ively, and the gradient elution program was 5–8% B for
0–5 min, 8–11% B for 5–30 min, 11%–18% B for 30–
45 min. Ideain and cyanidin 3-arabinoside were detected
at the wavelength of 520 nm, hyperoside and isoquerci-
trin were detected at the wavelength of 360 nm, (−)-epi-
catechin was detected at the wavelength of 280 nm, and
chlorogenic acid was detected at the wavelength of
330 nm. Data signals were acquired and processed using
LC-solution software.
Pharmacological activity of EPHF
Determination of antioxidant capacity
The antioxidant capacities of samples were evaluated
by measuring DPPH, AAPH free radical scavenging
activity. These two assays were carried out according
to our previously reported methods [16, 17]. Trolox
was used as positive control in both of the two anti-
oxidant experiments, and the capacity of scavenging
AAPH was expressed as Trolox equivalents (μmol
Trolox/mg extract).
Determination of cell growth inhibition activity
MCF-7 and SKOV-3 cells were cultured in DMEM sup-
plemented with 10% heat inactivated FBS, at 37 °C in a
humidified atmosphere of 95% air and 5% CO2. The cells
were seeded onto 96-well culture plate at a density of
3 × 103 cells/well and allowed to adhere for 24 h. The
cells were incubated with different doses (0.5, 5, 12.5, 25
and 50 mg/L) of samples for 48 h. All the reactions were
performed in six replicates.
Fig. 1 The HPLC chromatograms of reference (a) and sample solution (b) at 280 nm. Peaks 1 ~ 8: (1) chlorogenic acid; (2) procyanidin B2; (3)
ideain; (4) (−)-epicatechin; (5) cyanidin 3-arabinoside; (6) hyperoside; (7) isoquercitrin; (8) procyanidin C1
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The cell growth inhibition effect of EPHF was eval-
uated by MTT reduction. After 48 h incubation,
MTT solution in PBS was added in a final concentra-
tion of 0.5 mg/mL. The plate was incubated at 37 °C
for 4 h, followed by the addition of 150 μL DMSO to
dissolve the dark blue formazan crystals. The absorb-
ance at 570 nm was measured on a Varioskan Flash
Multimode Reader (Thermo Scientific, Finland). Cell
viability was calculated as the percentage of untreated
control.
Determination of AChE inhibitory activity
AChE-inhibiting activities were measured by the slightly
modified spectrophotometric method developed by
Ellman et al. [18, 19]. Briefly, 10 μL of Tris/HCl buffer
containing 20 mM Tris (pH 7.5), 80 μL of DTNB
(1 mM), 4 μL of sample, and 4 μL of AChE (2000 U)
were mixed in the wells and incubated for 10 min at
room temperature. The reaction was initiated by
addition of 2 μL of ATCI (20 mM). The microplate was
then read at a wavelength of 412 nm every 30 s for
15 min by a Varioskan Flash Multimode Reader (Thermo
Scientific, Finland). These samples were dissolved in
Tris/HCl buffer (containing 2% MeOH, v/v). All the re-
actions were performed in six replicates. Galanthamine
was used instead of EPHF in positive control group.
Results and discussion
The preparation of EPHF
In our previous study, Diaion HP-20 macroporous
resin was shown to be a good material to enrich
flavonoids in HF [20]. In the present paper, the flavo-
noids in PHF were enriched using Diaion HP-20
macroporous resin. The sample was eluted with water,
20%, and 60% ethanol all containing 0.1% (v/v) tri-
fluoroacetic acid subsequently, and the corresponding
eluents were analyzed by HPLC. The results showed
that flavonoids with diversified structures were
enriched in 20% ethanol eluent, while sugar was
enriched in the fraction eluted by water, and little fla-
vonoids were detected in 60% ethanol eluent. There-
fore, the fraction eluted by 20% ethanol was selected
for the next experiment.
Qualitative and quantitative analysis of EPHF
Optimization of the sample preparation
To get a high-extraction efficiency of the target com-
pounds from the sample, different extraction solvents
(hybrid solutions of ethanol and acid water), the
solvent-to-sample ratio, extraction methods (ultra-
sonic, reflux, and infrared-assisted reflux extraction),
temperature (20, 30, 40 and 50 °C) and time (30, 60
and 90 min) were studied. Sixty percent ethanol
(pH 2) as the solvent and ultrasonic extraction for
10 min at 30 °C was found to be suitable for the ex-
traction of the target compounds.
Qualitative analysis of EPHF
Chromatographic conditions were optimized for the
qualitative analysis of EPHF. In this process, several mo-
bile phases (hybrid systems of organic phase and acid
water) were studied, and the best separation result was
Table 1 Calibration curves, LODs and LOQs of the standard compounds
Compound Calibration curve r Linear range/μg LOQ/ng LOD/ng
Ideain Y = 5000000x-5992.1 0.9999 0.0049 ~ 0.63 4.93 2.47
Cyanidin 3-arabinoside Y = 5000000x-12627 0.9999 0.0049 ~ 0.63 4.89 2.44
Hyperoside Y = 3000000x-70021 0.9998 0.0049 ~ 5.02 4.90 2.45
Isoquercitrin Y = 3000000x-68963 0.9997 0.0049 ~ 5.01 4.89 2.45
(−)-Epicatechin Y = 835115x-7850.7 0.9999 0.0099 ~ 5.12 9.99 2.50
Chlorogenic acid Y = 4000000x-131307.7 0.9995 0.0050 ~ 2.57 5.01 2.50
Table 2 Precision and recovery for the developed HPLC method
Compound Precision RSD (%) Reproducibility Recovery
Intra-day Inter-day RSD (%) Average (%) RSD (%)
Ideain 1.45 1.45 1.38 98.39 3.60
Cyanidin 3-arabinoside 1.53 1.44 1.74 102.78 1.92
Hyperoside 1.46 1.93 2.12 100.68 0.73
Isoquercitrin 1.44 1.81 0.81 103.05 1.49
(−)-Epicatechin 1.36 1.92 1.72 101.51 3.15
Chlorogenic acid 1.76 1.72 0.34 99.05 0.99
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obtained when using an acetonitrile-formic acid solution
as mobile phase at 35 °C (Fig. 1).
Peaks 1 ~ 7 were identified as chlorogenic acid, pro-
cyanidin B2, ideain, (−)-epicatechin, cyanidin 3-
arabinoside, hyperoside and isoquercitrin by comparing
their retention times and UV spectra with those of
standard compounds (Fig. 1). Peak 8 was identified as
procyanidin C1 according to its precursor ion with an
m/z value of 867.21 [M +H] + and other characteristic
ions 289.07, 577.13, 579.15, 889.19 [21, 22].
Method validation for quantitative analysis
Method validation was performed on parameters such
as linearity, recovery and precision. Calibration curves
of 6 standard compounds (ideain, (−)-epicatechin,
chlorogenic acid, cyanidin 3-arabinoside, hyperoside
and isoquercitrin) were constructed from peak areas
versus compound amounts. The limit of quantification
(LOQ) and limit of detection (LOD) for each com-
pound were determined at signal-to-noise ratios of 10
and 3, respectively. The calibration data were shown
in Table 1. Relative standard deviation (RSD) value
was calculated, and it was considered as the measure
of precision. To assess the intra-day precision, the
standard solution was injected seven times within a
day. The inter-day precision test was assessed by test-
ing over three consecutive days (Table 2). The assay
method precision determination was carried out using
six independent sample solutions. The accuracy of
quantitation in terms of recovery was assessed. Stand-
ard solutions were spiked into the sample solution
containing half the mass of the plant material with
known amounts of the tested analytes, and the sam-
ple was extracted according to the procedure de-
scribed in sample preparation. The amount of each
analyte in the standard solution was almost equal to
that in the sample solution. The RSD values of repro-
ducibility were all less than 3%. The average recovery
rate of the six analytes ranged from 98.39 to 103.05%,
with RSD values varying between 0.73 and 3.60%
(Table 2).
In this paper, the contents of procyanidin B2 and
procyanidin C1 in sample were not determined, be-
cause of the limited availability of standard of procya-
nidin C1 and the poor chromatographic separation of
procyanidin B2.
Quantitative analysis of samples
The contents of the 6 compounds in both of EPHF and
PHF were determined, and result was shown in Table 3.
The results indicated that the contents of anthocyanin
and (−)-epicatechin and the total amount of the 6 com-
pounds in EPHF were much higher than those in PHF.
Obviously, the purification method of macroporous resin
is useful for the extraction and separation of the flavo-
noids from PHF.
Pharmacological activity of EPHF
Antioxidant capacity of EPHF
In this study, the antioxidant capacities of EPHF and
PHF were evaluated by measuring DPPH free radical
scavenging activity and oxygen radical absorbance cap-
acity (ORAC). The results indicated that EPHF exhibited
the strongest DPPH and AAPH free radical scavenging
capacity, followed by PHF and HF in a decreasing order
[23] (Table 4). Our previous studies have shown that
(−)-epicatechin, chlorogenic acid, hyperoside, isoquerci-
trin and procyanidin B2 all have strong free radical-
scavenging activity [16, 17], accordingly, the high
concentrations of the antioxidant ingredients in EPHF
contributed to the strong antioxidant activity of EPHF,
i.e., the higher the concentrations of the antioxidant in-
gredients, the stronger the antioxidant activity of the
sample.
The excessive free radicals in organs may bind to and
destroy body cells, and are considered to be the main
cause of some diseases, such as aging, cancer and car-
diovascular disease [24, 25]. Our results suggest that
EPHF may be the potential source of antioxidant agents
Table 3 Contents of compounds in samples/% (n = 2)
Samples Ideain Cyanidin 3-arabinoside Hyperoside Isoquercitrin (−)-Epicatechin Chlorogenic acid Total
EPHF 17.94 0.14 0.04 0.02 4.09 1.00 23.23
PHF 0.087 0.010 0.038 0.022 0.64 0.084 0.881
EPHF extract from the peel of hawthorn fruit, PHF peel of hawthorn fruit
Table 4 Free radical scavenging activity of samples (n = 6)
HF PHF EPHF Trolox
DPPH (IC50, μg/mL) 330 [17] 66.30 6.72 6.72
a/8.69b
ORAC (μmol/mg) 0.375 ± 0.4 [23] 1.27 ± 0.44 11.65 ± 2.37
EPHF extract from the peel of hawthorn fruit, PHF peel of hawthorn fruit, HF hawthorn fruit
aIC50 of Trolox in reference [17]
bIC50 of Trolox tested in the present experiment
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to be used as an alternative for the treatment of free
radical-associated disease.
AChE inhibitory activity of EPHF
In this study, the AChE inhibitory activity of EPHF,
PHF and HF were evaluated, and the result showed
that EPHF exhibited the highest AChE inhibitory ac-
tivity, followed in decreasing order by PHF and HF
(Table 5).
AChE plays an important role in the growth and
matureness of cell, and it also promotes the develop-
ment of neurons and the regeneration of nerves.
AChE inhibitor has been used as a drug for the
symptomatic treatment of Alzheimer’s disease [26].
Our results suggest that EPHF has a relatively strong
anti-AChE effect, indicating its potential to be used
as an alternative for the treatment of Alzheimer and
related disorders.
Effect of EPHF on cell growth of human carcinoma
EPHF significantly inhibited MCF-7, SKOV-3 cells
proliferation in a concentration-dependent manner
with the IC50 value of 2.76 and 80.11 μg/mL, respect-
ively. In Li’s study, the IC50 value of PHF and haw-
thorn fruit fleshes on MCF-7 cells were 88.6 and
175.5 μg/mL, respectively [27], which indicated that
EPHF might exhibit the stronger inhibitory effect
against MCF-7 cells compared with PHF.
In summary, the pharmacological result suggests the
potential of EPHF to be an alternative for the treatment
of free radical-associated diseases, and Alzheimer and
related disorders.
Conclusions
Macroporous resin is useful for the extraction and separ-
ation of the total flavonoids from PHF. The contents of
flavonoids especially anthocyanin in EPHF were in-
creased significantly compared with those in PHF and
HF. More importantly, the pharmacological experiments
showed that EPHF exhibited stronger DPPH and AAPH
free radical scavenging activity and AChE inhibitory ac-
tivity comparing with PHF and HF. Moreover, EPHF
inhibited the proliferation of cancer cells. As the first re-
port on the phytochemical compositions and pharmaco-
logical activity analysis of EPHF, the results of this study
was laying the foundation for further research on the




AChE: Acetylcholinesterase; ATCI: Acetyhhiocholine; DMEM: Dulbecco’s
modified Eagle’s medium; DPPH: 2,2-diphenyl-1-picryhydrazyl; DTNB: 5,5′-
dithiobis-(2-nitrobenzoic acid); EPHF: Extract from the peel of hawthorn fruit;
FL: Fluorescein disodium salt; HF: Hawthorn fruit; IC50: Half-maximal inhibitory
concentration; MTT: 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium
bromide; ORAC: Oxygen radical absorbance capacity; PHF: Peel of hawthorn
fruit
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